These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 31743601

  • 21. Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis.
    Del Prete E, Tommasini L, Mazzucchi S, Frosini D, Palermo G, Morganti R, Pagni C, Tognoni G, Bonuccelli U, Ceravolo R.
    Neurol Sci; 2021 Apr; 42(4):1483-1490. PubMed ID: 32851538
    [Abstract] [Full Text] [Related]

  • 22. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
    Picillo M, Cuoco S, Tepedino MF, Cappiello A, Volpe G, Erro R, Santangelo G, Pellecchia MT, Barone P, PSP Salerno study group.
    J Neurol; 2019 Jul; 266(7):1727-1735. PubMed ID: 30989369
    [Abstract] [Full Text] [Related]

  • 23. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E, Antonini A, Camparini V, Weis L, Semenza C, Biundo R.
    J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
    [Abstract] [Full Text] [Related]

  • 24. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
    Longoni G, Agosta F, Kostić VS, Stojković T, Pagani E, Stošić-Opinćal T, Filippi M.
    Mov Disord; 2011 Feb 01; 26(2):247-55. PubMed ID: 21412831
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic potential of automated tractography in progressive supranuclear palsy variants.
    Potrusil T, Krismer F, Beliveau V, Seppi K, Müller C, Troger F, Göbel G, Steiger R, Gizewski ER, Poewe W, Scherfler C.
    Parkinsonism Relat Disord; 2020 Mar 01; 72():65-71. PubMed ID: 32113070
    [Abstract] [Full Text] [Related]

  • 26. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S, Visser W, Schlegel U.
    J Voice; 2011 Nov 01; 25(6):725-31. PubMed ID: 20457507
    [Abstract] [Full Text] [Related]

  • 27. Differential Progression of Midbrain Atrophy in Parkinsonism: Longitudinal MRI Study.
    Hwang M, Yang H, Kim Y, Youn J, Park J, Huh YE, Kim HT, Cho JW.
    Neurodegener Dis; 2017 Nov 01; 17(1):31-37. PubMed ID: 27614955
    [Abstract] [Full Text] [Related]

  • 28. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
    Leiguarda RC, Pramstaller PP, Merello M, Starkstein S, Lees AJ, Marsden CD.
    Brain; 1997 Jan 01; 120 ( Pt 1)():75-90. PubMed ID: 9055799
    [Abstract] [Full Text] [Related]

  • 29. Diffusion tractography of superior cerebellar peduncle and dentatorubrothalamic tracts in two autopsy confirmed progressive supranuclear palsy variants: Richardson syndrome and the speech-language variant.
    Gatto RG, Martin PR, Ali F, Clark HM, Duffy JR, Utianski RL, Botha H, Machulda MM, Dickson DW, Josephs KA, Whitwell JL.
    Neuroimage Clin; 2022 Jan 01; 35():103030. PubMed ID: 35597031
    [Abstract] [Full Text] [Related]

  • 30. Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease.
    Pinkhardt EH, Jürgens R, Becker W, Valdarno F, Ludolph AC, Kassubek J.
    J Neurol; 2008 Dec 01; 255(12):1916-25. PubMed ID: 19224319
    [Abstract] [Full Text] [Related]

  • 31. Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.
    Schofield EC, Hodges JR, Macdonald V, Cordato NJ, Kril JJ, Halliday GM.
    Mov Disord; 2011 Feb 01; 26(2):256-63. PubMed ID: 21412832
    [Abstract] [Full Text] [Related]

  • 32. Phenotypic Spectrum of Progressive Supranuclear Palsy: Clinical Study and Apolipoprotein E Effect.
    Nasri A, Sghaier I, Neji A, Gharbi A, Abida Y, Mrabet S, Gargouri A, Djebara MB, Kacem I, Gouider R.
    J Mov Disord; 2024 Apr 01; 17(2):158-170. PubMed ID: 38290492
    [Abstract] [Full Text] [Related]

  • 33. Fluorodeoxyglucose positron emission tomography in Richardson’s syndrome and progressive supranuclear palsy-parkinsonism.
    Srulijes K, Reimold M, Liscic RM, Bauer S, Dietzel E, Liepelt-Scarfone I, Berg D, Maetzler W.
    Mov Disord; 2012 Jan 01; 27(1):151-5. PubMed ID: 22359740
    [Abstract] [Full Text] [Related]

  • 34. Differences in aphasia syndromes between progressive supranuclear palsy-Richardson's syndrome, behavioral variant frontotemporal dementia and Alzheimer's dementia.
    Ransmayr L, Fuchs A, Ransmayr-Tepser S, Kommenda R, Kögl M, Schwingenschuh P, Fellner F, Guger M, Eggers C, Darkow R, Mangesius S, Ransmayr G.
    J Neural Transm (Vienna); 2022 Aug 01; 129(8):1039-1048. PubMed ID: 35821453
    [Abstract] [Full Text] [Related]

  • 35. [Relations between alexithymia and anhedonia: a study in eating disordered and control subjects].
    Deborde AS, Berthoz S, Godart N, Perdereau F, Corcos M, Jeammet P.
    Encephale; 2006 Aug 01; 32(1 Pt 1):83-91. PubMed ID: 16633294
    [Abstract] [Full Text] [Related]

  • 36. Characterizing gait and exploring neuro-morphometry in patients with PSP-Richardson's syndrome and vascular parkinsonism.
    Chatterjee K, Paul S, Banerjee R, Choudhury S, Tiwari M, Basu P, Kumar H.
    Parkinsonism Relat Disord; 2023 Aug 01; 113():105483. PubMed ID: 37354829
    [Abstract] [Full Text] [Related]

  • 37. Levodopa modulates semantic fluency and uniqueness in non-demented patients with progressive supranuclear palsy.
    Ma J, Zhang G, Zhao Z, Chan P, Ye Z.
    Brain Behav; 2024 Jul 01; 14(7):e3606. PubMed ID: 38945805
    [Abstract] [Full Text] [Related]

  • 38. Track density imaging in progressive supranuclear palsy: A pilot study.
    Nigro S, Bianco MG, Arabia G, Morelli M, Nisticò R, Novellino F, Salsone M, Augimeri A, Quattrone A.
    Hum Brain Mapp; 2019 Apr 15; 40(6):1729-1737. PubMed ID: 30474903
    [Abstract] [Full Text] [Related]

  • 39. Improved Automatic Morphology-Based Classification of Parkinson's Disease and Progressive Supranuclear Palsy.
    Talai AS, Ismail Z, Sedlacik J, Boelmans K, Forkert ND.
    Clin Neuroradiol; 2019 Dec 15; 29(4):605-614. PubMed ID: 30218110
    [Abstract] [Full Text] [Related]

  • 40. Gait Analysis in Progressive Supranuclear Palsy Phenotypes.
    Picillo M, Ricciardi C, Tepedino MF, Abate F, Cuoco S, Carotenuto I, Erro R, Ricciardelli G, Russo M, Cesarelli M, Barone P, Amboni M.
    Front Neurol; 2021 Dec 15; 12():674495. PubMed ID: 34177779
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.